Plague history: Yersin’s discovery of the causative bacterium in 1894 enabled, in the subsequent century, scientific progress in understanding the disease and the development of treatments and vaccines

The causative bacterium of plague was described and cultured by Alexandre Yersin in Hong Kong in 1894, after which transmission of bacteria from rodents by flea bites was discovered by Jean-Paul Simond in 1898. Effective treatment with antiserum was initiated in 1896, but this therapy was supplanted...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical microbiology and infection 2014-03, Vol.20 (3), p.202-209
1. Verfasser: Butler, T.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 209
container_issue 3
container_start_page 202
container_title Clinical microbiology and infection
container_volume 20
creator Butler, T.
description The causative bacterium of plague was described and cultured by Alexandre Yersin in Hong Kong in 1894, after which transmission of bacteria from rodents by flea bites was discovered by Jean-Paul Simond in 1898. Effective treatment with antiserum was initiated in 1896, but this therapy was supplanted by sulphonamides in the 1930s and by streptomycin starting in 1947. India suffered an estimated 6 million deaths in 1900–1909, and Vietnam, during its war in 1965–1975, accounted for approximately 80% of the world’s cases; since then, African countries have dominated, with >90% of the world’s cases in the 1990s and early 21st century. Serological diagnosis with fraction 1 antigen to detect anti-plague antibodies was developed in the 1950s. Vaccine development started in 1897 with killed whole bacterial cells, and this was followed by a live attenuated bacterial vaccine, leading to millions of persons receiving injections, but the benefits of these vaccines remain clouded by controversy. Plasmid-mediated virulence was established in 1981, and this was followed by specific DNA methods that have allowed detection of plague genes in skeletal specimens from European graves of the sixth to 17th centuries.
doi_str_mv 10.1111/1469-0691.12540
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1785233547</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1198743X14608582</els_id><sourcerecordid>3912918041</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4950-c6bc47fe60cce6d0337dd51045bd45d3c32aef34f065bb3b597df1ff6bf677a03</originalsourceid><addsrcrecordid>eNqFkstu1TAQhiNERUthzQ5ZYsOiae34kpgdOuImnQoWIMHKcuzxqatcDnYSlB2vwTPxFjwJzknbBRKqF7Zn9M3vmfFk2TOCz0laF4QJmWMhyTkpOMMPspM7z8N0J7LKS0a_HmePY7zGGBeUskfZccEYrQrKT7Lfnxq9GwFd-Tj0YX6FvkGIvvvz81dE1kfTTxBm1Ds0XAEyeox68BOgWpsBgh9b5DtEKskQdLpuwJ4tjoWNYx3h-wjdgEzaxjCfoWh8unrnDdqHfhcgxgUfO5seHXRnfbc7BKeXQUdAybXaMEHT79tFbcklgB4WIx6ISRvjO4hPsiOnmwhPb87T7MvbN5837_Ptx3cfNq-3uWGS49yI2rDSgcDGgLCY0tJaTjDjtWXcUkMLDY4yhwWva1pzWVpHnBO1E2WpMT3NXq66qYhUYRxUmzoFTaM76MeoSFnx1GjOyvtRJuXyYyVP6It_0Ot-DF0qJAlyWkkhmEzUxUqZ0McYwKl98K0OsyJYLSOhFjm1DIA6jESKeH6jO9Yt2Dv-dgYSwFfgh29gvk9PbbaXt8JyjYPU68lDUIf_NWB9ADMo2_v_JvUX-mbXtg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1753896649</pqid></control><display><type>article</type><title>Plague history: Yersin’s discovery of the causative bacterium in 1894 enabled, in the subsequent century, scientific progress in understanding the disease and the development of treatments and vaccines</title><source>Wiley-Blackwell Journals</source><source>MEDLINE</source><source>Alma/SFX Local Collection</source><source>EZB Electronic Journals Library</source><creator>Butler, T.</creator><creatorcontrib>Butler, T.</creatorcontrib><description>The causative bacterium of plague was described and cultured by Alexandre Yersin in Hong Kong in 1894, after which transmission of bacteria from rodents by flea bites was discovered by Jean-Paul Simond in 1898. Effective treatment with antiserum was initiated in 1896, but this therapy was supplanted by sulphonamides in the 1930s and by streptomycin starting in 1947. India suffered an estimated 6 million deaths in 1900–1909, and Vietnam, during its war in 1965–1975, accounted for approximately 80% of the world’s cases; since then, African countries have dominated, with &gt;90% of the world’s cases in the 1990s and early 21st century. Serological diagnosis with fraction 1 antigen to detect anti-plague antibodies was developed in the 1950s. Vaccine development started in 1897 with killed whole bacterial cells, and this was followed by a live attenuated bacterial vaccine, leading to millions of persons receiving injections, but the benefits of these vaccines remain clouded by controversy. Plasmid-mediated virulence was established in 1981, and this was followed by specific DNA methods that have allowed detection of plague genes in skeletal specimens from European graves of the sixth to 17th centuries.</description><identifier>ISSN: 1198-743X</identifier><identifier>EISSN: 1469-0691</identifier><identifier>DOI: 10.1111/1469-0691.12540</identifier><identifier>PMID: 24438235</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Alexandre Yersin ; Animals ; Bacteria ; epidemics ; History, 19th Century ; History, 20th Century ; History, 21st Century ; Humans ; Incidence ; plague ; Plague - diagnosis ; Plague - drug therapy ; Plague - epidemiology ; Plague - history ; Plague - microbiology ; Plague - prevention &amp; control ; Plague Vaccine ; Yersin ; Yersinia pestis - isolation &amp; purification</subject><ispartof>Clinical microbiology and infection, 2014-03, Vol.20 (3), p.202-209</ispartof><rights>2014 European Society of Clinical Infectious Diseases</rights><rights>2014 The Authors Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infectious Diseases</rights><rights>2014 The Authors Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infectious Diseases.</rights><rights>Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infectious Diseases</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4950-c6bc47fe60cce6d0337dd51045bd45d3c32aef34f065bb3b597df1ff6bf677a03</citedby><cites>FETCH-LOGICAL-c4950-c6bc47fe60cce6d0337dd51045bd45d3c32aef34f065bb3b597df1ff6bf677a03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2F1469-0691.12540$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2F1469-0691.12540$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,27915,27916,45565,45566</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24438235$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Butler, T.</creatorcontrib><title>Plague history: Yersin’s discovery of the causative bacterium in 1894 enabled, in the subsequent century, scientific progress in understanding the disease and the development of treatments and vaccines</title><title>Clinical microbiology and infection</title><addtitle>Clin Microbiol Infect</addtitle><description>The causative bacterium of plague was described and cultured by Alexandre Yersin in Hong Kong in 1894, after which transmission of bacteria from rodents by flea bites was discovered by Jean-Paul Simond in 1898. Effective treatment with antiserum was initiated in 1896, but this therapy was supplanted by sulphonamides in the 1930s and by streptomycin starting in 1947. India suffered an estimated 6 million deaths in 1900–1909, and Vietnam, during its war in 1965–1975, accounted for approximately 80% of the world’s cases; since then, African countries have dominated, with &gt;90% of the world’s cases in the 1990s and early 21st century. Serological diagnosis with fraction 1 antigen to detect anti-plague antibodies was developed in the 1950s. Vaccine development started in 1897 with killed whole bacterial cells, and this was followed by a live attenuated bacterial vaccine, leading to millions of persons receiving injections, but the benefits of these vaccines remain clouded by controversy. Plasmid-mediated virulence was established in 1981, and this was followed by specific DNA methods that have allowed detection of plague genes in skeletal specimens from European graves of the sixth to 17th centuries.</description><subject>Alexandre Yersin</subject><subject>Animals</subject><subject>Bacteria</subject><subject>epidemics</subject><subject>History, 19th Century</subject><subject>History, 20th Century</subject><subject>History, 21st Century</subject><subject>Humans</subject><subject>Incidence</subject><subject>plague</subject><subject>Plague - diagnosis</subject><subject>Plague - drug therapy</subject><subject>Plague - epidemiology</subject><subject>Plague - history</subject><subject>Plague - microbiology</subject><subject>Plague - prevention &amp; control</subject><subject>Plague Vaccine</subject><subject>Yersin</subject><subject>Yersinia pestis - isolation &amp; purification</subject><issn>1198-743X</issn><issn>1469-0691</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkstu1TAQhiNERUthzQ5ZYsOiae34kpgdOuImnQoWIMHKcuzxqatcDnYSlB2vwTPxFjwJzknbBRKqF7Zn9M3vmfFk2TOCz0laF4QJmWMhyTkpOMMPspM7z8N0J7LKS0a_HmePY7zGGBeUskfZccEYrQrKT7Lfnxq9GwFd-Tj0YX6FvkGIvvvz81dE1kfTTxBm1Ds0XAEyeox68BOgWpsBgh9b5DtEKskQdLpuwJ4tjoWNYx3h-wjdgEzaxjCfoWh8unrnDdqHfhcgxgUfO5seHXRnfbc7BKeXQUdAybXaMEHT79tFbcklgB4WIx6ISRvjO4hPsiOnmwhPb87T7MvbN5837_Ptx3cfNq-3uWGS49yI2rDSgcDGgLCY0tJaTjDjtWXcUkMLDY4yhwWva1pzWVpHnBO1E2WpMT3NXq66qYhUYRxUmzoFTaM76MeoSFnx1GjOyvtRJuXyYyVP6It_0Ot-DF0qJAlyWkkhmEzUxUqZ0McYwKl98K0OsyJYLSOhFjm1DIA6jESKeH6jO9Yt2Dv-dgYSwFfgh29gvk9PbbaXt8JyjYPU68lDUIf_NWB9ADMo2_v_JvUX-mbXtg</recordid><startdate>201403</startdate><enddate>201403</enddate><creator>Butler, T.</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7U9</scope><scope>C1K</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>7X8</scope></search><sort><creationdate>201403</creationdate><title>Plague history: Yersin’s discovery of the causative bacterium in 1894 enabled, in the subsequent century, scientific progress in understanding the disease and the development of treatments and vaccines</title><author>Butler, T.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4950-c6bc47fe60cce6d0337dd51045bd45d3c32aef34f065bb3b597df1ff6bf677a03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Alexandre Yersin</topic><topic>Animals</topic><topic>Bacteria</topic><topic>epidemics</topic><topic>History, 19th Century</topic><topic>History, 20th Century</topic><topic>History, 21st Century</topic><topic>Humans</topic><topic>Incidence</topic><topic>plague</topic><topic>Plague - diagnosis</topic><topic>Plague - drug therapy</topic><topic>Plague - epidemiology</topic><topic>Plague - history</topic><topic>Plague - microbiology</topic><topic>Plague - prevention &amp; control</topic><topic>Plague Vaccine</topic><topic>Yersin</topic><topic>Yersinia pestis - isolation &amp; purification</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Butler, T.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Virology and AIDS Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical microbiology and infection</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Butler, T.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Plague history: Yersin’s discovery of the causative bacterium in 1894 enabled, in the subsequent century, scientific progress in understanding the disease and the development of treatments and vaccines</atitle><jtitle>Clinical microbiology and infection</jtitle><addtitle>Clin Microbiol Infect</addtitle><date>2014-03</date><risdate>2014</risdate><volume>20</volume><issue>3</issue><spage>202</spage><epage>209</epage><pages>202-209</pages><issn>1198-743X</issn><eissn>1469-0691</eissn><abstract>The causative bacterium of plague was described and cultured by Alexandre Yersin in Hong Kong in 1894, after which transmission of bacteria from rodents by flea bites was discovered by Jean-Paul Simond in 1898. Effective treatment with antiserum was initiated in 1896, but this therapy was supplanted by sulphonamides in the 1930s and by streptomycin starting in 1947. India suffered an estimated 6 million deaths in 1900–1909, and Vietnam, during its war in 1965–1975, accounted for approximately 80% of the world’s cases; since then, African countries have dominated, with &gt;90% of the world’s cases in the 1990s and early 21st century. Serological diagnosis with fraction 1 antigen to detect anti-plague antibodies was developed in the 1950s. Vaccine development started in 1897 with killed whole bacterial cells, and this was followed by a live attenuated bacterial vaccine, leading to millions of persons receiving injections, but the benefits of these vaccines remain clouded by controversy. Plasmid-mediated virulence was established in 1981, and this was followed by specific DNA methods that have allowed detection of plague genes in skeletal specimens from European graves of the sixth to 17th centuries.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>24438235</pmid><doi>10.1111/1469-0691.12540</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1198-743X
ispartof Clinical microbiology and infection, 2014-03, Vol.20 (3), p.202-209
issn 1198-743X
1469-0691
language eng
recordid cdi_proquest_miscellaneous_1785233547
source Wiley-Blackwell Journals; MEDLINE; Alma/SFX Local Collection; EZB Electronic Journals Library
subjects Alexandre Yersin
Animals
Bacteria
epidemics
History, 19th Century
History, 20th Century
History, 21st Century
Humans
Incidence
plague
Plague - diagnosis
Plague - drug therapy
Plague - epidemiology
Plague - history
Plague - microbiology
Plague - prevention & control
Plague Vaccine
Yersin
Yersinia pestis - isolation & purification
title Plague history: Yersin’s discovery of the causative bacterium in 1894 enabled, in the subsequent century, scientific progress in understanding the disease and the development of treatments and vaccines
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T20%3A23%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Plague%20history:%20Yersin%E2%80%99s%20discovery%20of%20the%20causative%20bacterium%20in%201894%20enabled,%20in%20the%20subsequent%20century,%20scientific%20progress%20in%20understanding%20the%20disease%20and%20the%20development%20of%20treatments%20and%20vaccines&rft.jtitle=Clinical%20microbiology%20and%20infection&rft.au=Butler,%20T.&rft.date=2014-03&rft.volume=20&rft.issue=3&rft.spage=202&rft.epage=209&rft.pages=202-209&rft.issn=1198-743X&rft.eissn=1469-0691&rft_id=info:doi/10.1111/1469-0691.12540&rft_dat=%3Cproquest_cross%3E3912918041%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1753896649&rft_id=info:pmid/24438235&rft_els_id=S1198743X14608582&rfr_iscdi=true